First US implant of RENEW, interspinous allograft technology for treatment of lumbar spinal stenosis
Published date : 04 June 2010
Article date : 04 June 2010
The first commercial implant recently took place in the US of the RENEW Interspinous Allograft Technology (Interventional Spine) for the treatment of lumbar spinal stenosis (LSS).
The RENEW Implant is an interspinous process device made from allograft for the treatment of lumbar spinal stenosis. Designed for ease of implant and to provide a more ‘natural’ interference within the spinous process, the company believes that this innovative device will improve outcomes and provide cost efficiencies to hospitals and surgeons.
The implant is available in six different sizes to accommodate the patient’s anatomy.
The first implant was performed at the Inova Fairfax Hospital in Fairfax, Virginia, by Dr Ronald C Childs. Upon completing the procedure, Childs commented: “I am very pleased with this product. The use of the RENEW implant provides, in my view, a welcomed alternative to the other various interspinous process devices made from synthetic materials presently in the market.”
